1. Home
  2. CKX vs AYTU Comparison

CKX vs AYTU Comparison

Compare CKX & AYTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CKX Lands Inc.

CKX

CKX Lands Inc.

HOLD

Current Price

$10.79

Market Cap

23.0M

Sector

Energy

ML Signal

HOLD

Logo Aytu BioPharma Inc.

AYTU

Aytu BioPharma Inc.

HOLD

Current Price

$2.17

Market Cap

25.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CKX
AYTU
Founded
1930
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.0M
25.7M
IPO Year
1998
N/A

Fundamental Metrics

Financial Performance
Metric
CKX
AYTU
Price
$10.79
$2.17
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$9.33
AVG Volume (30 Days)
4.7K
81.9K
Earning Date
03-25-2026
02-03-2026
Dividend Yield
N/A
N/A
EPS Growth
2.14
N/A
EPS
0.23
N/A
Revenue
$897,333.00
$62,640,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$47.32
P/E Ratio
$46.97
N/A
Revenue Growth
N/A
2.00
52 Week Low
$8.66
$0.95
52 Week High
$13.25
$3.07

Technical Indicators

Market Signals
Indicator
CKX
AYTU
Relative Strength Index (RSI) 58.82 34.81
Support Level $10.53 $2.13
Resistance Level $11.15 $2.50
Average True Range (ATR) 0.21 0.14
MACD -0.06 -0.05
Stochastic Oscillator 36.01 4.76

Price Performance

Historical Comparison
CKX
AYTU

About CKX CKX Lands Inc.

CKX Lands Inc is a Louisiana corporation organized to receive non-producing mineral royalties spun off by a southwest Louisiana bank. It operates in three segments: Oil and Gas, Surface, and Timber. The company owns land and mineral interests and collects income through its ownership of oil and gas royalties, surface leases for farming, the right of way and other uses, and timber sales. The company's oil and gas royalties are paid by the operators who own the wells, and timber income is paid by the highest bidder for the timber. CKX has small royalty interests in approximately 20 different producing oil and gas fields. Maximum revenue for the company is generated from the Surface segment. Geographically, it generates all of its revenue from the United States of America.

About AYTU Aytu BioPharma Inc.

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline, including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates one business segment consisting of various prescription pharmaceutical products sold through third parties.

Share on Social Networks: